Shay Capital’s Eli Lilly LLY Stock Holding History

Shay Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,572	Closed	-$1.69M	–	576
2025 Q4	$1.69M	Buy	+1,572	New	+$1.5M	0.17%	132
2025 Q3	–	Sell	-350	Closed	-$273K	–	468
2025 Q2	$273K	Buy	350 +15	+4%	+$11.7K	0.03%	230
2025 Q1	$277K	Buy	+335	New	+$279K	0.04%	207
2024 Q4	–	Sell	-505	Closed	-$447K	–	376
2024 Q3	$447K	Buy	+505	New	+$454K	0.06%	175
2024 Q2	–	Sell	-1,200	Closed	-$934K	–	356
2024 Q1	$934K	Buy	1,200 +600	+100%	+$427K	0.15%	120
2023 Q4	$350K	Sell	600 -420	-41%	-$245K	0.07%	165
2023 Q3	$548K	Buy	+1,020	New	+$526K	0.08%	157
2023 Q2	–	Sell	-1,350	Closed	-$464K	–	510
2023 Q1	$464K	Buy	+1,350	New	+$455K	0.09%	182
2022 Q4	–	Sell	-1,000	Closed	-$323K	–	351
2022 Q3	$323K	Buy	+1,000	New	+$317K	0.07%	193

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Shay Capital's LLY Position: Q1 2026 in Review

Shay Capital sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 1,572 shares — an estimated $1.69M sold.

Shay Capital first reported a position in LLY in Q3 2022 and held it in 9 quarters. The position peaked at $1.69M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Shay Capital reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
Shay Capital sold 1,572 Eli Lilly shares in Q1 2026, an estimated $1.69M.
Shay Capital first reported a position in Eli Lilly in Q3 2022 and held it in 9 quarters.
Shay Capital's Eli Lilly position peaked at $1.69M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Shay Capital's 13F filing for Q1 2026, filed 15 May 2026.